Robert H. Vonderheide, MD, DPhil

For groundbreaking research involving the integration of basic and clinical investigations to advance the establishment of novel cancer immunotherapies such as vaccines, antibody-based therapies, and adoptive T-cell therapies, and for defining the immunobiology of tumor microenvironments through the use of genetically engineered mouse models.

*Full-length biography in development